Gland Pharma Share Price Target 2024, 2025, 2027, 2030, 2040

Today in our blog we are going to explain the basic idea about Gland Pharma Share Price Target  2024, 2025, 2027, 2030, 2040. We did the research and took advice from experts to make this blog about company growth, the company’s performance, etc.

Gland Pharma Company is the oldest company in the pharmaceutical market. Its net profit has been high last few years, especially from the Covid Situation. In today’s article, we are trying to give a details idea about the company’s growth, market value, etc. So, if anyone wants to invest in Gland Pharma Share at the end of the blog, you can get a better experience about Gland Pharma Share Price Target. Let’s look at Gland Pharma Share Price Target 2024, 2025, 2027, 2030, 2040.

What is Gland Pharma Share?

Gland Pharma Company is mainly a pharmaceutical company, which was established in 1978 in Hyderabad, India. The main function of Gland Pharma Company is to manufacture and marketing of injection and some types of medicine. The Share price of Gland Pharma Share is always high because the demand of the medical sector always is there day and night.

Overview Of Gland Pharma Company

Gland Pharma Company’s medicine and injectables are manufactured in India some of which are also manufactured in Europe, but supplies the products outside of countries like Canada, the United States, South Africa, and Australia. Gland Pharma Company also produces different types of medical equipment like- small vials, ampoules, syringes, etc.

Some Details About Gland Pharma Company

Also read- Adani Power Share Price Target

Some important data about company performance

Before investing in any Shares, everybody wants to know about the company’s annual growth rate, the company’s overall performance, the demand of the company in the share market, etc. So, before discussing Gland Pharma Share we want to give some idea about the company’s performance.

PE Ratio (Price To Earning Ratio)

PE Ratio is calculated by Market price per share Earning price per share. It means the number of times an investor is ready to pay as compared to earnings time. Gland Pharma Company has a PE ratio of 28.58, which is not so low.

Return on Assets (ROA)

ROA is calculated by Profit After tax ÷ Total Assets. ROA is influenced by 2 factors return on sales and asset turnover. Gland Pharma Company has a ROA of 10.95%, which is not so high.

Current Ratio

The current Ratio is calculated by Current Assets ÷ Current Liabilities. Gland Pharma Company has a current ratio of 7.94.

Return On Equity (ROE)

ROE is measured by = Net profit ÷ Average Share holding equity. Gland Pharma Company has a ROE of 12.33%, which is high.

Gland Pharma Share Price Target 2024, 2025, 2027, 2030, 2040

If we look at the previous Gland Pharma Share hit lower circuits but last 3 years the performance of this share has been very high from the Covid situation especially. If we think about the future of the Gland Pharma Share it will always be in a high position because the medical sector is always a very necessary thing for everybody.

The demand for the medical sector never decreases. Gland Pharma Company has a good promoter holding capacity of 55.23% which is significant for the company’s growth. Let’s look at Gland Pharma Share Price Target from 2024 to 2040.

Also read- Patel Engineering Share Price Target

Gland Pharma Share Price Target 2024

Gland Pharma Company always focuses on research and development for that reason this company can manufacture new equipment and medicine according to market demand. Gland Pharma Company is associated with more than 1500 private and governmental hospitals, health care centers, and nursing homes for supplying medical equipment and medicine. From different hospitals and health centers, Gland Pharma Company gains huge profit.

For more the number of private and government hospital pharma companies like Gland Pharma also can spread their business in the market. Gland Pharma Company also supplies many new technology equipment according to hospital demand as a result Gland Pharma Company gains more profit and the growth revenue of the company becomes very high. The 1st Price Target of Gland Pharma Share Price Target 2024 is ₹1,785.36 and the 2nd Price Target is ₹2,163.01.

Gland Pharma Share Price Target 2025

A big part of the business revenue of Gland Pharma Company comes from the United States. Above 60% of the company’s revenue growth comes from the United States. The United States is a very developed country for research and development purposes, the same reason pharmaceutical company also more focused on the research and development field.

The management of Gland Pharma Company also decided to invest a huge amount in research and development purposes, as a result, the company will be able to produce new equipment with new technology, and the annual sales and profit of the company will grow more. Gland Pharma Company is a pharmaceutical company that is attached to modern treatment processes, which are always updated with new progress. For this reason, the company also tries to develop a regular basis through research and development to gain more profit. The 1st Price Target of Gland Pharma Share Price Target 2025 is ₹2,232.01 and the 2nd Price Target is ₹2,469.74.

Gland Pharma Share Price Target 2027

Gland Pharma Company exports all its products out of India. Pashamylaram Hyderabad, Penems Hyderabad, and Dundigal Hyderabad are the places from where Gland Pharma Company exports all of its products out of India.

In recent times more than 40% stake of Gland Pharma Company is held by Fosun, Singapur, which is part of Fosun International. Fosun Is a China pharmaceutical company that is a platform for medical equipment and medicine supplies company. Fosun Pharmaceutical has modern research and development capabilities. With the help of Fosun Pharmaceutical company Gland Pharma Company also be able to do more development in the research field and also be linked up through the global world. For this reason, Gland Pharma Company also grew its business Besides that Gland Pharma Share Price increased. The 1st Price Target of Gland Pharma Share Price Target 2027 is ₹2,814.92 and the 2nd Price Target is ₹3,087.23.

Gland Pharma Share Price Target 2030

Gland Pharma is a pharmaceutical company so the demand for the company never decreases. Especially from the Covid situation pharma company become one of the essential things for everyone. The demand for pharmaceutical drugs and normal medical equipment(like Nebulizer, Pulse Oximeters, glucometers, etc)also increased to a very high level. For that reason, the demand for Gland Pharma Company also increase. Gland Pharma Company also increase its annual profit above 15%.

Gland Pharma Company is also attached to other companies like Fosun, Singapur which are also international pharmaceutical companies so Gland Pharma also be able to spread its business to an international level. Gland Pharma Company also be able to hold a good marketplace in the pharmaceutical market area.

As Gland Pharma Company will grow its business Gland Pharma Share also be profitable on a long-term basis. The company exports its products to the United States and Canada so the company has foreign investors also. Many good investors are also interested in investing in Gland Pharma Share as Gland Pharma Company has good market holding capacity, good market value, good cash flow ratio, good profit revenue, and good money turnover ratio. If anyone wants to invest in Gland Pharma Share on a long-term basis it will be beneficial. The 1st Price Target of Gland Pharma Share Price Target 2030 is ₹3,745.85 and the 2nd Price Target is ₹3,962.13.

Gland Pharma Share Price Target 2040

For calculating Gland Pharma Share Price for 2040 we also should look at the last 5 years company’s growth, sales growth, and net profit growth. The net profit margin of Gland Pharma Company is approximately 20 to 22% and sales growth is also 20% which is not so low in range.

Gland Pharma company has scientists more than 200 who always examine the product quality and then get approval to export the product to a foreign country the company has the expertise and always looks after the company’s net profit, company’s financial growth, and market value. so that’s why Gland Pharma Company always tries to improve and in the future, it must be a valuable share of the market. The 1st Price Target of Gland Pharma Share Price Target 2040 is ₹6,124.93 and the 2nd Price Target is ₹6,365.14.

Investors types and ratio of Gland Pharma Company

There are mainly four Types of Investors in Gland Pharma Company.

Promoters Holding (55.59%)

Promoters Holding means how much capital is invested by company promoters (owner of the company) through overall capital. For Gland Pharma Share promoter holding capacity is 55.59%.

Public Holding (14.38%)

Public Investors an individuals who invest in the public market for profit in the future (large and small companies). For Gland Pharma Share public Holding capacity is 14.38%.

FII (Foreign Institutional Investors) 3.02%

Foreign Institutional Investors are those big companies that invest in different countries company. For Gland Pharma company FII is 3.02%.

DII (Domestic Institutional Investors) 27.01%

Domestic Institutional Investors (like Insurance, companies mutual funds) who invest in their own country. For Gland Pharma Company DII is 27.01%.

Should I Invest or Not in Gland Pharma Company Right Now?

Gland Pharma Company started as a small pharmaceutical company that produces small injectables and medicines. But now after the attachment with Fosun, Singapur Gland Pharma Company has increased more. With the growth of Gland Pharma Company, Gland Pharma Share also increased. A few years back Gland Pharma Company lost its market but at the current time, Gland Pharma Company is making more profit, especially from the Covid situation. The company’s profit revenue, money turnover ratio, and sales rate are high. So, if anyone wants to invest in Gland Pharma Share they can gain more profit on a long-term basis. Before invest must consult with a specialist.

Advantages and Disadvantages Of Gland Pharma Share

Every share has some advantages and some disadvantages also. So, Gland Pharma Share also has some advantages and disadvantages which are described below.

Advantages

• Gland Pharma Company has a good promoter holding capacity (55.56%), for the good performance of the company many good investors have also seen interest in investing in Gland Pharma Share.
• Gland Pharma Company is a pharmaceutical company, so it has huge demand in the market. Gland Pharma Company is also attached to many private and government hospitals for this reason the demand for Gland Pharma Company also increased.
• Gland Pharma Company also exports its product to the United States, Canada, and South Africa for this reason a huge part of the company’s growth revenue comes from foreign investors.
• Gland Pharma Company is always able to make improvements through recharge and development, especially after attachment with Fosun, Singapur. They have a special team for doing research and making products according to market demand.

Disadvantages

• There are many pharmaceutical companies in the market so there is always a chance for a high rate of competition in the pharmaceutical market.

FAQ

Conclusion

Hopefully, www.sharetargethub.com will help you gain some basic ideas about Gland Pharma Share Price Target. By doing the research and taking advice from expertise we ensure that on a long-term basis, Gland Pharma Share Price Target may reach a very high position. As Gland Pharma is related to the pharmaceutical industry, So the demand for this sector also increases which helps the share to gain profit in the future.

If you think this website will be helpful for you then you can share it. If you have any questions please let us know through the comment box we will try to reply to your questions and solve your problem. Thanks for visiting this website and thanks for being with us.

Disclaimer – We are not SEBI-registered advisors. A financial market is always risky to anyone. This website is only for training and educational purposes. So before investing, we are requested to discuss certified expertise. We will not be responsible for anyone’s profit or loss.